Sodium chloride (inhalation): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Protected "Sodium chloride (inhalation)": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(7 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{DrugProjectFormSinglePage
{{DrugProjectFormSinglePage
|authorTag=
|authorTag={{AV}}
 
|OTC=Yes
 
|genericName=sodium chloride inhalant
<!--Overview-->
|aOrAn=an
 
|drugClass=aerosol
|genericName=
|indicationType=procedure
 
|indication=respiratory therapy or for tracheal or lavage.
 
|adverseReactions=[[allergic reaction]]
 
|blackBoxWarningTitle=Title
|aOrAn=
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
 
a
 
|drugClass=
 
 
 
|indication=
 
 
 
|hasBlackBoxWarning=
 
Yes
 
|adverseReactions=
 
 
 
<!--Black Box Warning-->
 
|blackBoxWarningTitle=
Title
 
|blackBoxWarningBody=
<i><span style="color:#FF0000;">ConditionName: </span></i>


* Content
* Content
Line 42: Line 16:


<!--FDA-Labeled Indications and Dosage (Adult)-->
<!--FDA-Labeled Indications and Dosage (Adult)-->
 
|fdaLIADAdult=Intended for use in respiratory therapy or for tracheal or lavage. This sterile, single-use device is intended to be used as an accessory to medicinal nonventilatory nebulizers for respiratory therapy or for tracheal irrigation or lavage therapy.
|fdaLIADAdult=
=====Dosing Information=====
 
*Directions for use: To verify container integrity, squeeze the vial before use. Twist cap completely off vial, invert and squeeze prescribed volume.
=====Condition1=====
*Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
* Dosing Information
 
:* Dosage
 
=====Condition3=====
 
* Dosing Information
 
:* Dosage
 
=====Condition4=====
 
* Dosing Information
 
:* Dosage
 
<!--Off-Label Use and Dosage (Adult)-->
<!--Off-Label Use and Dosage (Adult)-->


<!--Guideline-Supported Use (Adult)-->
<!--Guideline-Supported Use (Adult)-->
 
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultGuideSupport=
 
=====Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Non–Guideline-Supported Use (Adult)-->
<!--Non–Guideline-Supported Use (Adult)-->
 
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultNoGuideSupport=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Pediatric Indications and Dosage-->
<!--Pediatric Indications and Dosage-->


<!--FDA-Labeled Indications and Dosage (Pediatric)-->
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
 
|fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
|fdaLIADPed=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.


<!--Off-Label Use and Dosage (Pediatric)-->
<!--Off-Label Use and Dosage (Pediatric)-->


<!--Guideline-Supported Use (Pediatric)-->
<!--Guideline-Supported Use (Pediatric)-->
 
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedGuideSupport=
 
=====Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Non–Guideline-Supported Use (Pediatric)-->
<!--Non–Guideline-Supported Use (Pediatric)-->
 
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedNoGuideSupport=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Contraindications-->
<!--Contraindications-->
|contraindications=<!--Warnings-->
|warnings=*Not for injection or in preparations to be used for injection.


|contraindications=
*This device is not for parenteral use or for preparations intended for parenteral use.


* Condition1
*CAUTION: Contents are sterile in the unopened, undamaged package.


<!--Warnings-->


|warnings=
* Description
====Precautions====
* Description


<!--Adverse Reactions-->
<!--Adverse Reactions-->


<!--Clinical Trials Experience-->
<!--Clinical Trials Experience-->
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.


|clinicalTrials=
There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
=====Body as a Whole=====
=====Cardiovascular=====
=====Digestive=====
=====Endocrine=====
=====Hematologic and Lymphatic=====
=====Metabolic and Nutritional=====
=====Musculoskeletal=====
=====Neurologic=====
=====Respiratory=====
=====Skin and Hypersensitivy Reactions=====
=====Special Senses=====
=====Urogenital=====
=====Miscellaneous=====






<!--Postmarketing Experience-->
<!--Postmarketing Experience-->
 
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=
 
There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
 
=====Body as a Whole=====
 
 
 
=====Cardiovascular=====
 
 
 
=====Digestive=====
 
 
 
=====Endocrine=====
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
=====Metabolic and Nutritional=====
 
 
 
=====Musculoskeletal=====
 
 
 
=====Neurologic=====
 
 
 
=====Respiratory=====
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
=====Special Senses=====
 
 
 
=====Urogenital=====
 
 
 
=====Miscellaneous=====
 




<!--Drug Interactions-->
<!--Drug Interactions-->
 
|drugInteractions=<!--Use in Specific Populations-->
|drugInteractions=
|useInPregnancyAUS=There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
 
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
* Drug
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
:* Description
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
 
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
<!--Use in Specific Populations-->
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
 
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInPregnancyFDA=
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
* '''Pregnancy Category'''
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
 
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInPregnancyAUS=
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
 
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
 
|useInLaborDelivery=
There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=
There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
 
|useInPed=
There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
 
|useInGeri=
There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
 
|useInGender=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
 
|useInRace=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
 
|useInHepaticImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
 
|useInReproPotential=
There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
 
|useInImmunocomp=
There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->
|administration=* Inhalant
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.


|administration=
* Oral
* Intravenous
|monitoring=
There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
* Description


<!--IV Compatibility-->
<!--IV Compatibility-->
 
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|IVCompat=
 
There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.


<!--Overdosage-->
<!--Overdosage-->
 
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
|overdose=
 
===Acute Overdose===
 
====Signs and Symptoms====
 
* Description
 
====Management====
 
* Description
 
===Chronic Overdose===
 
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


<!--Pharmacology-->
<!--Pharmacology-->


<!--Drug box 2-->
<!--Drug box 2-->
|drugBox={{Chembox2
| Verifiedfields = changed     
| Watchedfields = changed
| verifiedrevid = 477002432
| ImageFile1 = Halit-Kristalle.jpg
| ImageFile2 = NaCl polyhedra.png
| ImageSize1 = 200px
| ImageSize2 = 200px
| IUPACName = Sodium chloride
| OtherNames = Common salt<br />
Halite<br />
Rock salt<br />
Saline<br />
Sodium chloric<br />
Table salt
| Section1 = {{Chembox Identifiers
| CASNo = 7647-14-5
| CASNo_Ref = {{cascite|correct|CAS}}
| PubChem = 5234
| PubChem_Ref = {{Pubchemcite|correct|pubchem}}
| UNII = 451W47IQ8X
| UNII_Ref = {{fdacite|correct|FDA}}
| EINECS = 231-598-3
| KEGG = D02056
| KEGG_Ref = {{keggcite|correct|kegg}}
| MeSHName = Sodium+chloride
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 26710
| ChEMBL = 1200574
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| RTECS = VZ4725000
| ATCCode_prefix = A12
| ATCCode_suffix = CA01
| ATC_Supplemental = {{ATC|B05|CB01}}, {{ATC|B05|XA03}}, {{ATC|S01|XA03}}
| Beilstein = 3534976
| Gmelin = 13673
| SMILES = [Na+].[Cl-]
| StdInChI = 1S/ClH.Na/h1H;/q;+1/p-1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| InChI = 1/ClH.Na/h1H;/q;+1/p-1
| StdInChIKey = FAPWRFPIFSIZLT-UHFFFAOYSA-M
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| InChIKey = FAPWRFPIFSIZLT-REWHXWOFAE
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5044
}}
| Section2 = {{Chembox Properties
| Formula = NaCl
| MolarMass = 58.44 g mol<sup>−1</sup>
| ExactMass = 57.958622382 g mol<sup>−1</sup>
| Appearance = Colorless crystals
| Odor = Odorless     
| Density = 2.165 g/cm<sup>3</sup>
| MeltingPtC = 801
| BoilingPtC = 1413
| Solubility = 359 g/L
| Solvent1 = ammonia
| Solubility1 = 21.5 g/L
| Solvent2 = methanol
| Solubility2 = 14.9 g/L
| RefractIndex = 1.5442 (at 589 nm)
}}
| Section3 = {{Chembox Structure
| CrystalStruct = Face-centered cubic <br>(''see text''), [[Pearson symbol|cF8]]
| SpaceGroup = Fm{{overline|3}}m, No. 225
| LattConst_a = 564.02 pm
| Coordination = Octahedral (Na<sup>+</sup>)<br />Octahedral (Cl<sup>−</sup>)
}}
| Section4 = {{Chembox Thermochemistry
| DeltaHf = −411.12 kJ mol<sup>−1</sup>
| Entropy = 72.11 J K<sup>−1</sup> mol<sup>−1</sup>
| HeatCapacity = 36.79 J K<sup>−1</sup> mol<sup>−1</sup>
}}
| Section5 = {{Chembox Hazards
| NFPA-H = 1
| NFPA-F = 0
| NFPA-R = 0
| LD50 = 3000 mg/kg (oral, rats)<ref>http://chem.sis.nlm.nih.gov/chemidplus/rn/7647-14-5</ref>
}}
| Section6 = {{Chembox Related
| OtherAnions = [[Sodium fluoride]]<br />[[Sodium bromide]]<br />[[Sodium iodide]]
| OtherCations = [[Lithium chloride]]<br />[[Potassium chloride]]<br />[[Rubidium chloride]]<br />[[Caesium chloride]]
}}


|drugBox=
}}<!--Mechanism of Action-->
 
|mechAction=<!--Structure-->
 
|structure=<!--Pharmacodynamics-->
 
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
<!--Mechanism of Action-->
 
|mechAction=
 
*
 
<!--Structure-->
 
|structure=
 
*
 
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
 
<!--Pharmacodynamics-->
 
|PD=
 
There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.


<!--Pharmacokinetics-->
<!--Pharmacokinetics-->
 
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
|PK=
 
There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.


<!--Nonclinical Toxicology-->
<!--Nonclinical Toxicology-->
 
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
|nonClinToxic=
 
There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.


<!--Clinical Studies-->
<!--Clinical Studies-->
 
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
|clinicalStudies=
 
There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.


<!--How Supplied-->
<!--How Supplied-->
|howSupplied=*Sodium Chloride Inhalation Solution, 0.9% is supplied in single-use plastic vials in the following packaging configurations.
:*NDC 0487-9301-03 3 mL, 100 vials per carton
:*NDC 0487-9301-33 3 mL, 30 vials per carton/1 vial per foil pouch
:*NDC 0487-9302-01 5 mL, 100 vials per carton
:*Internal contents sterile. External surface of vial not sterile.


|howSupplied=
*Store at controlled room temperature 15° to 30°C (59° to 86°F).
 
*  


<!--Patient Counseling Information-->
<!--Patient Counseling Information-->
 
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=
 
There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.


<!--Precautions with Alcohol-->
<!--Precautions with Alcohol-->
 
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|alcohol=
 
* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.


<!--Brand Names-->
<!--Brand Names-->
 
|brandNames=*
|brandNames=
 
* ®<ref>{{Cite web | title =  | url =  }}</ref>


<!--Look-Alike Drug Names-->
<!--Look-Alike Drug Names-->
 
|lookAlike=<!--Drug Shortage Status-->
|lookAlike=
 
* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
 
<!--Drug Shortage Status-->
 
|drugShortage=
|drugShortage=
}}
}}
<!--Pill Image-->
<!--Pill Image-->


Line 475: Line 217:


{{LabelImage
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
|fileName={{PAGENAME}}01.png|This image is provided by the National Library of Medicine.
}}
}}


{{LabelImage
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
|fileName={{PAGENAME}}02.png|This image is provided by the National Library of Medicine.
}}
{{LabelImage
|fileName={{PAGENAME}}03.png|This image is provided by the National Library of Medicine.
}}
}}
<!--Category-->
<!--Category-->


[[Category:Drug]]
[[Category:Drug]]

Latest revision as of 17:09, 20 August 2015

Sodium chloride (inhalation)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Sodium chloride (inhalation) is an aerosol that is FDA approved for the procedure of respiratory therapy or for tracheal or lavage.. Common adverse reactions include allergic reaction.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Intended for use in respiratory therapy or for tracheal or lavage. This sterile, single-use device is intended to be used as an accessory to medicinal nonventilatory nebulizers for respiratory therapy or for tracheal irrigation or lavage therapy.

Dosing Information
  • Directions for use: To verify container integrity, squeeze the vial before use. Twist cap completely off vial, invert and squeeze prescribed volume.
  • Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Sodium chloride (inhalation) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Sodium chloride (inhalation) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Sodium chloride (inhalation) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Sodium chloride (inhalation) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Sodium chloride (inhalation) in pediatric patients.

Contraindications

There is limited information regarding Sodium chloride (inhalation) Contraindications in the drug label.

Warnings

  • Not for injection or in preparations to be used for injection.
  • This device is not for parenteral use or for preparations intended for parenteral use.
  • CAUTION: Contents are sterile in the unopened, undamaged package.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Sodium chloride (inhalation) in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Sodium chloride (inhalation) in the drug label.

Drug Interactions

There is limited information regarding Sodium chloride (inhalation) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Sodium chloride (inhalation) in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Sodium chloride (inhalation) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Sodium chloride (inhalation) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Sodium chloride (inhalation) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Sodium chloride (inhalation) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Sodium chloride (inhalation) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Sodium chloride (inhalation) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Sodium chloride (inhalation) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Sodium chloride (inhalation) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Sodium chloride (inhalation) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Sodium chloride (inhalation) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Sodium chloride (inhalation) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Inhalant

Monitoring

There is limited information regarding Monitoring of Sodium chloride (inhalation) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Sodium chloride (inhalation) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Sodium chloride (inhalation) in the drug label.

Pharmacology

Template:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox BeilsteinTemplate:Chembox ECNumberTemplate:Chembox E numberTemplate:Chembox GmelinTemplate:Chembox RTECSTemplate:Chembox AppearanceTemplate:Chembox OdourTemplate:Chembox DensityTemplate:Chembox MeltingPtTemplate:Chembox BoilingPtTemplate:Chembox SolubilityInWaterTemplate:Chembox SolubilityTemplate:Chembox SolubilityTemplate:Chembox RefractIndexTemplate:Chembox StructureTemplate:Chembox ThermochemistryTemplate:Chembox NFPATemplate:Chembox Lethal amounts (set)Template:Chembox OtherAnionsTemplate:Chembox OtherCationsTemplate:Chembox Supplement
Template:Chembox header2 | Sodium chloride (inhalation)
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG
MeSH Sodium+chloride
UNII
Properties
NaCl
Molar mass 58.44 g mol−1
Hazards
Related compounds
Template:Chembox header2 | Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)
Infobox disclaimer and references

Mechanism of Action

There is limited information regarding Sodium chloride (inhalation) Mechanism of Action in the drug label.

Structure

There is limited information regarding Sodium chloride (inhalation) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Sodium chloride (inhalation) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Sodium chloride (inhalation) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Sodium chloride (inhalation) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Sodium chloride (inhalation) in the drug label.

How Supplied

  • Sodium Chloride Inhalation Solution, 0.9% is supplied in single-use plastic vials in the following packaging configurations.
  • NDC 0487-9301-03 3 mL, 100 vials per carton
  • NDC 0487-9301-33 3 mL, 30 vials per carton/1 vial per foil pouch
  • NDC 0487-9302-01 5 mL, 100 vials per carton
  • Internal contents sterile. External surface of vial not sterile.
  • Store at controlled room temperature 15° to 30°C (59° to 86°F).

Storage

There is limited information regarding Sodium chloride (inhalation) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Sodium chloride (inhalation) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Sodium chloride (inhalation) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Sodium chloride (inhalation) in the drug label.

Precautions with Alcohol

  • Alcohol-Sodium chloride (inhalation) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

There is limited information regarding Sodium chloride (inhalation) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ http://chem.sis.nlm.nih.gov/chemidplus/rn/7647-14-5



{{#subobject: 

 |Label Page=Sodium chloride (inhalation)
 |Label Name=Sodium chloride (inhalation)01.png

}}


{{#subobject: 

 |Label Page=Sodium chloride (inhalation)
 |Label Name=Sodium chloride (inhalation)02.png

}}

{{#subobject: 

 |Label Page=Sodium chloride (inhalation)
 |Label Name=Sodium chloride (inhalation)03.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Sodium_chloride_(inhalation)&oldid=1137552"